Skip to content

    Migraines & Headaches Health Center

    Font Size
    A
    A
    A

    Power of Suggestion Shown in Study of Migraine Drug

    Expectation plays important role in response to treatment, expert says

    WebMD News from HealthDay

    By Mary Brophy Marcus

    HealthDay Reporter

    WEDNESDAY, Jan. 8, 2014 (HealthDay News) -- A new study of migraine sufferers suggests that what you're told when your doctor prescribes medication can influence your body's response to it.

    Researchers from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston compared the effects of a common migraine drug and an inactive placebo in 66 people who suffer from migraines. The condition includes throbbing headache, nausea, vomiting and sensitivity to light and sound.

    The results consistently showed that taking the pills accompanied by positive information increased the effectiveness of the treatment, whether the patient had taken the real deal -- the drug Maxalt -- or a pill labeled "placebo."

    Headache specialist Dr. Andrew Charles said the study demonstrates that expectation about response plays an important role in the ultimate response to a treatment.

    "When migraine patients were told by their doctor that a pill would help ease their headaches, this advice seemed to produce results whether or not the pill was a real migraine medication or a dummy placebo," said Charles, professor and director of the headache research and treatment program in the department of neurology at University of California School of Medicine, Los Angeles.

    "Relief was still higher with the actual medicine, so drugs do work beyond the placebo effect, but the researchers say that the placebo effect may still account for half of the therapeutic value of a drug," said Charles, who was not involved in the research.

    For the study, published online Jan. 8 in the journal Science Translational Medicine, the scientists studied more than 450 migraine attacks in the study participants, following them over seven separate episodes.

    To establish a baseline, each person was asked to report their pain and symptoms 30 minutes after the onset of an unmedicated migraine episode, and again 2.5 hours after its onset.

    Each participant then received six treatment envelopes. The envelopes were labeled in one of three ways: "Maxalt" (rizatriptan); "placebo"; or "Maxalt or placebo." The labels were true for four attacks and false for two attacks.

    1 | 2 | 3

    Today on WebMD

    Business woman with hand on face and eyes closed
    What aura looks like, triggers, and more.
    woman with migraine
    Get the truth about migraines.
     
    headache in the bedroom
    Keep headaches from ruining your sex life.
    woman with hands on head
    Test your knowledge of triggers, types, and more.
     
    woman with migraine
    Quiz
    drinking coffee
    Article
     
    Migraines Headaches Basics
    Article
    acupuncture needles in woman's back
    Slideshow
     
    Tired young man
    Slideshow
    spraying perfume
    Article
     
    man with a headache
    Article
    headache in the bedroom
    Article